Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding. 2004

Qing Huai, and Huanchen Wang, and Wei Zhang, and Robert W Colman, and Howard Robinson, and Hengming Ke
Department of Biochemistry and Biophysics and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7260, USA.

Cyclic nucleotide phosphodiesterases (PDEs) are enzymes controlling cellular concentrations of the second messengers cAMP and cGMP. The crystal structure of the catalytic domain of PDE9A2, a member of a PDE family specifically hydrolyzing cGMP, has been determined at 2.23-A resolution. The PDE9A2 catalytic domain closely resembles the cAMP-specific PDE4D2 but is significantly different from the cGMP-specific PDE5A1, implying that each individual PDE family has its own characteristic substrate recognition mechanism. The different conformations of the H and M loops between PDE9A2 and PDE5A1 imply their less critical roles in nucleotide recognition. The nonselective inhibitor 3-isobutyl-1-methylxanthine (IBMX) binds to a similar subpocket in the active sites of PDE4, PDE5, and PDE9 and has a common pattern of the binding. However, significantly different orientations and interactions of IBMXs are observed among the three PDE families and also between two monomers of the PDE9A2 dimer. The kinetic properties of the PDE9A2 catalytic domain similar to those of full-length PDE9A imply that the N-terminal regulatory domain does not significantly alter the catalytic activity and the IBMX inhibition.

UI MeSH Term Description Entries
D008670 Metals Electropositive chemical elements characterized by ductility, malleability, luster, and conductance of heat and electricity. They can replace the hydrogen of an acid and form bases with hydroxyl radicals. (Grant & Hackh's Chemical Dictionary, 5th ed) Metal
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010726 Phosphodiesterase Inhibitors Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. Phosphodiesterase Antagonists,Phosphodiesterase Inhibitor,Phosphoric Diester Hydrolase Inhibitors,Antiphosphodiesterases,Inhibitor, Phosphodiesterase
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities

Related Publications

Qing Huai, and Huanchen Wang, and Wei Zhang, and Robert W Colman, and Howard Robinson, and Hengming Ke
January 1985, The International journal of biochemistry,
Qing Huai, and Huanchen Wang, and Wei Zhang, and Robert W Colman, and Howard Robinson, and Hengming Ke
April 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Qing Huai, and Huanchen Wang, and Wei Zhang, and Robert W Colman, and Howard Robinson, and Hengming Ke
December 1984, Endocrinology,
Qing Huai, and Huanchen Wang, and Wei Zhang, and Robert W Colman, and Howard Robinson, and Hengming Ke
December 1988, Acta crystallographica. Section C, Crystal structure communications,
Qing Huai, and Huanchen Wang, and Wei Zhang, and Robert W Colman, and Howard Robinson, and Hengming Ke
March 2004, The Journal of biological chemistry,
Qing Huai, and Huanchen Wang, and Wei Zhang, and Robert W Colman, and Howard Robinson, and Hengming Ke
June 1985, Experientia,
Qing Huai, and Huanchen Wang, and Wei Zhang, and Robert W Colman, and Howard Robinson, and Hengming Ke
June 2002, Biochemical pharmacology,
Qing Huai, and Huanchen Wang, and Wei Zhang, and Robert W Colman, and Howard Robinson, and Hengming Ke
October 2002, FEBS letters,
Qing Huai, and Huanchen Wang, and Wei Zhang, and Robert W Colman, and Howard Robinson, and Hengming Ke
December 1994, Archives of ophthalmology (Chicago, Ill. : 1960),
Qing Huai, and Huanchen Wang, and Wei Zhang, and Robert W Colman, and Howard Robinson, and Hengming Ke
January 1981, Acta biologica et medica Germanica,
Copied contents to your clipboard!